№ lp_2_3_46062
File format: docx
Character count: 2723
File size: 79 KB
Year:
20XX
Region / city:
London
Topic:
Measles, Mumps, Rubella
Document type:
Request form
Organ / institution:
UK Health Security Agency (UKHSA)
Author:
Health Protection Team
Target audience:
Parents/guardians of individuals suspected of having measles, mumps, or rubella
Action period:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Context:
Request form for submitting oral fluid samples to confirm the presence of Measles, Mumps, or Rubella in individuals, with instructions for completing and returning the form and sample.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Region / city:
England
Topic:
Vaccination
Document type:
Patient Group Direction (PGD)
Organization:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Dr Vanessa Saliba, David Green
Target audience:
Healthcare practitioners
Validity period:
20 January 2026 – 30 November 2028
Approval date:
20 January 2026
Review date:
31 May 2028
Expiry date:
30 November 2028
Note:
Change history
Year:
2025
Region / city:
England
Topic:
Vaccination
Document type:
Patient Group Direction (PGD)
Issuing organization:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Dr. Vanessa Saliba, David Green
Target audience:
Healthcare practitioners authorized to administer vaccines
Valid from:
1 January 2026
Review date:
31 May 2028
Expiry date:
30 November 2028
Version:
7.0
Date of approval:
19 December 2025
Amendments:
Last amendment on 19 December 2025
Year:
N/A
Region / City:
N/A
Topic:
Immunization Requirements for Staff in Childcare Programs
Document Type:
Staff Documentation / Worksheet
Organization / Institution:
EEC-regulated childcare programs
Author:
N/A
Target Audience:
Childcare staff responsible for maintaining immunization records
Period of Validity:
N/A
Approval Date:
N/A
Date of Revisions:
N/A
Year:
1963
Region / City:
United States
Topic:
Mumps, Vaccine Development
Document Type:
Medical Case Study
Organization:
Merck
Author:
Erin Allmann Updyke, Erin Welsh
Target Audience:
General Public, Medical Enthusiasts
Period of Action:
March 1963
Date of Approval:
N/A
Date of Changes:
N/A
Note:
Contextual Description
Year:
2026
Region / city:
England
Topic:
Vaccination
Document type:
Patient Group Direction (PGD)
Organization:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Dr Vanessa Saliba, David Green
Target audience:
Healthcare practitioners
Validity period:
20 January 2026 – 30 November 2028
Approval date:
20 January 2026
Review date:
31 May 2028
Expiry date:
30 November 2028
Note:
Change history
Year:
2025
Region / city:
England
Topic:
Vaccination
Document type:
Patient Group Direction (PGD)
Issuing organization:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Dr. Vanessa Saliba, David Green
Target audience:
Healthcare practitioners authorized to administer vaccines
Valid from:
1 January 2026
Review date:
31 May 2028
Expiry date:
30 November 2028
Version:
7.0
Date of approval:
19 December 2025
Amendments:
Last amendment on 19 December 2025
Year:
N/A
Region / City:
N/A
Topic:
Immunization Requirements for Staff in Childcare Programs
Document Type:
Staff Documentation / Worksheet
Organization / Institution:
EEC-regulated childcare programs
Author:
N/A
Target Audience:
Childcare staff responsible for maintaining immunization records
Period of Validity:
N/A
Approval Date:
N/A
Date of Revisions:
N/A
Year:
2012
Region / city:
CDC
Topic:
Molecular Epidemiology, Genotyping
Document type:
Protocol
Organization:
CDC
Author:
CDC
Target audience:
Laboratories, Research Institutions
Period of validity:
N/A
Approval date:
03/06/2012
Date of amendments:
N/A
Purpose:
Amplification of 2 fragments from the rubella virus (RuV) envelope protein 1 (E1) coding region
PCR product sizes:
Fragment 1 (480 nts), Fragment 2 (633 nts)
Required equipment:
Thermocycler, Micropipettors, Class II biological safety cabinet
RNA preparation:
Extraction from clinical samples or cell cultures
Primers:
RV8633, RV8945, RV9112, RV9577
Control RNA:
Dried rubella RNA control
Handling instructions:
Store primers and control RNA at specified temperatures, prepare working solutions before use
Safety recommendations:
Use dedicated equipment and workspaces for RNA procedures
Contextual description:
Protocol for Rubella virus genotyping using RT-PCR to amplify specific RNA fragments, primarily for molecular epidemiological research.
Year:
Not specified
Region / City:
Not specified
Topic:
Neonatal Medicine, Pediatrics
Document Type:
Case Report
Organization / Institution:
Ziauddin University
Author:
Not specified
Target Audience:
Medical students, Healthcare professionals
Period of Action:
Not specified
Date of Approval:
Not specified
Date of Amendments:
Not specified
Year:
2023
Region / City:
Global
Subject:
Measles & Rubella Genotyping
Document Type:
Instruction Manual
Author:
N/A
Target Audience:
Researchers, Laboratory Technicians
Date of Approval:
N/A
Date of Changes:
N/A
Note:
Year
Topic:
Measles testing, PCR and serology
Document Type:
Procedure
Organization / Institution:
Public Health Ontario
Target Audience:
Healthcare professionals, laboratory staff
Year:
2024
Region/City:
Healthcare settings
Theme:
Measles risk assessment, infection control
Document Type:
Risk assessment guidelines
Organization/Institution:
Healthcare Safety Executive (HSE)
Author:
Not specified
Target Audience:
Healthcare organizations, employers, practitioners
Period of validity:
Ongoing, requires regular review
Approval Date:
19 March 2024
Date of Changes:
Not specified
Year:
1968
Region / City:
United Kingdom
Topic:
Vaccination, Measles, Immunology
Document Type:
Educational Text
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Students, Health professionals
Effective Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2023
Region / City:
United States
Theme:
Measles Awareness
Document Type:
Public Service Announcement
Organization:
Kansas Department of Health and Environment (KDH&E)
Target Audience:
General public, especially those unvaccinated or at risk
Period of Action:
Ongoing
Approval Date:
N/A
Date of Changes:
N/A
Year:
2026
Region / city:
England
Topic:
Vaccination
Document type:
Patient Group Direction (PGD)
Organization:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Dr Vanessa Saliba, David Green
Target audience:
Healthcare practitioners
Validity period:
20 January 2026 – 30 November 2028
Approval date:
20 January 2026
Review date:
31 May 2028
Expiry date:
30 November 2028
Note:
Change history
Year:
2025
Region / city:
England
Topic:
Vaccination
Document type:
Patient Group Direction (PGD)
Issuing organization:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Dr. Vanessa Saliba, David Green
Target audience:
Healthcare practitioners authorized to administer vaccines
Valid from:
1 January 2026
Review date:
31 May 2028
Expiry date:
30 November 2028
Version:
7.0
Date of approval:
19 December 2025
Amendments:
Last amendment on 19 December 2025
Year:
Not specified
Region / city:
Not specified
Theme:
Measles detection
Document type:
Protocol
Organization / institution:
EuroImmun
Author:
Not specified
Target audience:
Laboratory personnel, medical researchers
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Note:
Date
Topic:
Healthcare exposure, measles
Document Type:
Notification letter
Organization / Institution:
[Healthcare Facility]
Author:
[Health Officer Name]
Target Audience:
Patients, healthcare workers, pregnant women, individuals with compromised immunity
Context:
A template letter informing individuals of potential exposure to measles in a healthcare setting, providing instructions to assess their immunity and take necessary precautions.
Year:
2023
Region / City:
Spokane
Subject:
Measles surveillance
Document type:
Health assessment form
Organization:
Spokane Regional Health District
Author:
Unknown
Target audience:
Health care providers
Period of validity:
N/A
Approval date:
N/A
Modification date:
N/A
Year:
N/A
Region / City:
N/A
Topic:
Immunization Requirements for Staff in Childcare Programs
Document Type:
Staff Documentation / Worksheet
Organization / Institution:
EEC-regulated childcare programs
Author:
N/A
Target Audience:
Childcare staff responsible for maintaining immunization records
Period of Validity:
N/A
Approval Date:
N/A
Date of Revisions:
N/A